NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
PRODUCT SEARCH
Check product status including pharmaceutical, natural & cosmetic products.
COVID-19
As NPRA's mission is to safeguard the nation's health, NPRA has kept up to date with current situations and provide guidance during this period.
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
To report a suspected side effect or adverse drug reaction (ADR) to any medicine or vaccine
Consumers
ConSERF, AEFI Reporting, RiMUP, Product Cancellation & etc
Health Professionals
Safety Alert, Reporting ADR, MADRAC, Product Complaints, Publications
Industries
Product Registration, QUEST3+ System, Guideline Central, Application Forms, FAQs.
Additional Indications Approved |
List Of GLP Compliant Test Facilities |
Safety Updates on COVID-19 Vaccines: Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) / Thrombosis with Thrombocytopenia Syndrome (TTS) |
Biosimilars Approved |
Warfarin: Risk of Anticoagulant-Related Nephropathy (ARN) |
| 10 Aug 2022; 08:00AM - 05:00PM MOPI Virtual Training : MTP 4.0 - Industry 4.0 for Medical Technology, Biotechnology & Pharmaceuticals |
| 18 Jul 2022; 08:00AM - 05:00PM MOPI Virtual Training : Introduction to Laboratory Controls |
| 21 Jun 2022; 08:00AM - 05:00PM MOPI Virtual Training : Process Validation |
| 07 Jun 2022; 08:00AM - 05:00PM MOPI Virtual Training : Statistics for Life Science Industry |
| 23 May 2022; 08:00AM - 05:00PM MOPI Virtual Training : Computer Systems for Regulated Environment |
